Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.5801
-0.0899 (-13.42%)
At close: Apr 22, 2026, 4:00 PM EDT
0.5999
+0.0198 (3.41%)
After-hours: Apr 22, 2026, 7:58 PM EDT
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $56.65 million as of April 22, 2026. Its market cap has increased by 46.39% in one year.
Market Cap
56.65M
Enterprise Value
32.62M
1-Year Change
46.39%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $56.65M, a decrease of -70.72%. That is a compound annual growth rate of -13.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 56.60M | 135.83% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spruce Biosciences | 70.93M |
| MediciNova | 69.89M |
| ImmuCell | 69.84M |
| Acrivon Therapeutics | 68.19M |
| Cingulate | 68.14M |
| Edesa Biotech | 67.98M |
| OnKure Therapeutics | 66.73M |
| iBio, Inc. | 66.32M |